Where Will Technology Take Pharma In 2016?
This article was originally published in Scrip
Non-traditional healthcare partnerships are on the increase, including collaborative deals between big pharmas and technology giants such as Apple Inc. and Google. But what changes could these business partnerships – which have increased over the past few years – have in the long-term on the pharmaceutical and biotech industry?
You may also be interested in...
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.